Xcout Intel
Ferring Ventures
Ferring Ventures is a research company based in Kuopio, Finland, specializing in the translational field of cell therapy. The organization focuses on the discovery, establishment, and development of Advanced Therapy Medicinal Products (ATMPs) through Phase I and IIa clinical trials.
Subscribe to see Ferring Ventures’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ferring Ventures at a glance
Ferring Ventures is a biotechnology company headquartered in Switzerland. Xcout tracks 10 named people at Ferring Ventures, including Jean-Frédéric Paulsen (Managing Director).
Ferring Ventures leadership
- Jean-Frédéric PaulsenManaging Director
- Tuija KekarainenScientific Director -Site Head
- Joonas MalinenOperations Manager
- Katja SirviöCMC Manager
- Olga GurvichAnalytical Manager
- Sini SuomalainenProgram Manager
4 more named people on record for Ferring Ventures, with roles, board committees and tenure — see the full roster →
Ferring Ventures competitors
A few of Ferring Ventures's closest competitors — see the full list of competitors and alternatives →
Forward Pharma A/S is a clinical-stage biotechnology company driven by research and discovery, with headquarters located in Denmark.
Blue Cell Therapeutics is a biotechnology company founded in Copenhagen that focuses on revolutionizing the treatment of erectile dysfunction using specialized cell therapy.
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
TreeFrog Therapeutics is a French-based biotech company headquartered in Pessac, France. It aims to make iPS-derived cell therapies safer, more efficient, and more affordable to cure millions of patients.
TILT Biotherapeutics is a Finnish biotechnology company developing tumor-targeted immunotherapies, including oncolytic adenoviruses designed to stimulate immune responses against solid tumors. Its therapies are intended for cancer patients and are developed through clinical and pharmaceutical partnerships.
Cellaïon is a privately held biotechnology company founded in March 2021 and headquartered in Mont-Saint-Guibert, Belgium. The firm operates in the field of cell therapy and liver regenerative medicine, developing advanced therapies aimed at repairing tissues and regenerating organs. Additionally, Cellaïon runs clinical trials for conditions such as urea cycle disorders, inborn errors of metabolism, acute hepatic failure, and hepatic cirrhosis.
Get Ferring Ventures's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ferring Ventures in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access